Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > S Jeffrey Farrow > Profile

S Jeffrey Farrow

Affiliations

  • See Remarks at Tarsus Pharmaceuticals Inc. (TARS), 2025-06-18
  • Chief Financial Officer at Global Blood Therapeutics Inc. (GBT), 2022-10-06
  • Chief Financial Officer at Zs Pharma Inc. (ZSPH), 2015-12-22
  • Cfo at Hyperion Therapeutics Inc (HPTX), 2015-05-08
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TARS $40.42 13,608 $550,035.36 36,704 2025-06-17 Filing
TARS $50.11 1,186 $59,430.46 22,431 2025-03-20 Filing
TARS $47.40 1,254 $59,439.60 23,617 2025-03-19 Filing
TARS $46.29 1,284 $59,436.36 24,871 2025-03-18 Filing
TARS $27.47 10,445 $286,924.15 18,136 2024-06-18 Filing